bay y3118 has been researched along with cefoxitin in 2 studies
| Studies (bay y3118) | Trials (bay y3118) | Recent Studies (post-2010) (bay y3118) | Studies (cefoxitin) | Trials (cefoxitin) | Recent Studies (post-2010) (cefoxitin) |
|---|---|---|---|---|---|
| 37 | 0 | 0 | 2,131 | 362 | 328 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fresnadillo-Martínez, MJ; García-García, MI; García-Rodríguez, JA; García-Sánchez, E; García-Sánchez, JE; Trujillano-Martín, I | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
2 other study(ies) available for bay y3118 and cefoxitin
| Article | Year |
|---|---|
In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoxitin; Chloramphenicol; Clindamycin; Fluoroquinolones; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Quinolones | 1995 |
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; beta-Lactamases; Cefoxitin; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 1993 |